Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

NGM BIOPHARMACEUTICALS INC (NGM) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 4 Guyer Shelly D (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 78,407 options to buy @ $3.69, valued at $289.3k
05/12/2023 4 RIEFLIN WILLIAM JL (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 78,407 options to buy @ $3.69, valued at $289.3k
05/12/2023 4 Hooper Suzanne Sawochka (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 78,407 options to buy @ $3.69, valued at $289.3k
05/12/2023 4 GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 78,407 options to buy @ $3.69, valued at $289.3k
05/12/2023 4 PERLMUTTER ROGER M (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 78,407 options to buy @ $3.69, valued at $289.3k
05/12/2023 4 Ho Carole (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 78,407 options to buy @ $3.69, valued at $289.3k
03/06/2023 4 Nolan Mangini Siobhan (President and CFO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 76,000 shares @ $0
Granted 228,000 options to buy @ $4.36, valued at $994.1k
Granted 200,000 options to buy @ $4.36, valued at $872k
03/06/2023 4 WOODHOUSE DAVID J (CEO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 127,200 shares @ $0
Granted 381,600 options to buy @ $4.36, valued at $1.7M
Granted 500,000 options to buy @ $4.36, valued at $2.2M
03/06/2023 4 Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 53,000 shares @ $0
Granted 159,000 options to buy @ $4.36, valued at $693.2k
03/06/2023 4 CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 64,000 shares @ $0
Granted 192,000 options to buy @ $4.36, valued at $837.1k
Granted 175,000 options to buy @ $4.36, valued at $763k
03/06/2023 4 Pierce Valerie L (SVP, GC & CCO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 49,000 shares @ $0
Granted 147,000 options to buy @ $4.36, valued at $640.9k
Granted 150,000 options to buy @ $4.36, valued at $654k
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 9,900 shares @ $4.9994, valued at $49.5k
01/25/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 9,900 shares @ $4.9994, valued at $49.5k
01/25/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 9,900 shares @ $4.9994, valued at $49.5k
01/25/2023 4 GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 9,900 shares @ $4.9994, valued at $49.5k
01/23/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 37,639 shares @ $4.9976, valued at $188.1k
Bought 500 shares @ $4.996, valued at $2.5k
01/23/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 37,639 shares @ $4.9976, valued at $188.1k
Bought 500 shares @ $4.996, valued at $2.5k
01/23/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 37,639 shares @ $4.9976, valued at $188.1k
Bought 500 shares @ $4.996, valued at $2.5k
01/23/2023 4 GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 37,639 shares @ $4.9976, valued at $188.1k
Bought 500 shares @ $4.996, valued at $2.5k
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 5,378 shares @ $4.9466, valued at $26.6k
01/17/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 5,378 shares @ $4.9466, valued at $26.6k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 100,070 shares @ $4.8418, valued at $484.5k
Bought 209,000 shares @ $4.76, valued at $994.8k
01/12/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 100,070 shares @ $4.8418, valued at $484.5k
Bought 209,000 shares @ $4.76, valued at $994.8k
01/12/2023 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 100,070 shares @ $4.8418, valued at $484.5k
Bought 209,000 shares @ $4.76, valued at $994.8k
01/12/2023 4 GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 100,070 shares @ $4.8418, valued at $484.5k
Bought 209,000 shares @ $4.76, valued at $994.8k
12/14/2022 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 300 shares @ $4.9767, valued at $1.5k
12/14/2022 4 COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Bought 300 shares @ $4.9767, valued at $1.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy